Financial reports
10-K
2023 FY
Annual report
16 Apr 24
NT 10-K
Notice of late annual filing
1 Apr 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
30 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
Current reports
8-K
Movano Health Reports 2023 Financial Results and Provides Business Update
4 Apr 24
8-K
Entry into a Material Definitive Agreement
3 Apr 24
8-K
Movano Health Announces Over $1M Black Friday Holiday Launch Results for the Evie Ring as well as Cuffless Blood Pressure Milestone Achievement
29 Nov 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
17 Nov 23
8-K
Movano Health Announces Proposed Public Offering
15 Nov 23
8-K
Movano Health Provides Business Update and Reports Third Quarter 2023 Financial Results
15 Nov 23
8-K
Movano Health Provides Business Update and Reports Second Quarter 2023 Financial Results
14 Aug 23
8-K
Amendments to Articles of Incorporation or Bylaws
21 Jun 23
8-K
Movano Health Announces Proposed Public Offering
13 Jun 23
8-K
Movano Health Provides Business Update and Reports First Quarter 2023 Financial Results
15 May 23
Registration and prospectus
S-3
Shelf registration
23 Apr 24
D
$24.13 mm in equity / options, sold $24.13 mm, 185 investors
17 Apr 24
424B5
Prospectus supplement for primary offering
16 Nov 23
424B5
Prospectus supplement for primary offering
14 Nov 23
424B5
Prospectus supplement for primary offering
13 Jun 23
424B5
Prospectus supplement for primary offering
12 Jun 23
424B5
Prospectus supplement for primary offering
31 Jan 23
424B5
Prospectus supplement for primary offering
26 Jan 23
S-8
Registration of securities for employees
15 Aug 22
424B5
Prospectus supplement for primary offering
15 Aug 22
Other
EFFECT
Notice of effectiveness
26 May 22
CORRESP
Correspondence with SEC
24 May 22
UPLOAD
Letter from SEC
8 Apr 22
EFFECT
Notice of effectiveness
23 Mar 21
CERT
Certification of approval for exchange listing
22 Mar 21
CORRESP
Correspondence with SEC
18 Mar 21
CORRESP
Correspondence with SEC
18 Mar 21
CORRESP
Correspondence with SEC
25 Feb 21
UPLOAD
Letter from SEC
5 Feb 21
UPLOAD
Letter from SEC
27 Jul 20